60
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Early Drug Safety Evaluation: Biomarkers, Signatures, and Fingerprints

, , , , &
Pages 269-275 | Published online: 12 Aug 2003

References

  • Barbare J., Imbert A., Benkirane A. Hepatotoxicity of medications. Presse Medicine 2001; 30: 673–676
  • Bayly A. C. Nongenotoxic hepatocarcinogenesis in vitro: the Fao hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. Journal of Cell Science 1993; 104: 307–315
  • Bayly A. C., Roberts R. A., Dive C. Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. Journal of Cell Biology 1994; 125: 197–203
  • Branca F. Biomarkers in health and disease. British Journal of Nutrition 2001; 86: S55–S92
  • Cahill D. Protein and antibody arrays and their medical applications. Inmmunological Methods 2001; 250: 81–89
  • Coyle B. Characterization of the TGFβ1-induced apoptotic transcriptome in FaO hepatoma cells. Journal of Biological Chemistry 2003; 278: 5920–5928
  • Freathy C. TGFβ1 induces apoptosis in rat FaO hepatoma cells via cytochrome C release and oligomerization of Apaf 1 to form a ˜700 Kd apoptosome caspase processing complex. Hepatology 2000; 32: 750–760
  • Fung E., Wright G. J., Dalmasso E. Proteomic strategies for biomarker identification; progress and challenges. Current Opinion in Molecular Therapeutics 2000; 2: 643–650
  • Goodman Z. Drug hepatotoxicity. Clin. Liver Disease 2002; 6: 381–397
  • Gygi S. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 1999; 17: 994–999
  • Hautekeete M. Hepatotoxicity of antibiotics. Acta Gastroenterol. Belg. 1995; 58: 290–296
  • Jaeschke H. Mechanisms of hepatotoxicity. Toxicological Science 2002; 65: 166–176
  • Kennedy S. The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers 2002; 7: 269–290
  • McDonald W., Yates J. R. Shotgun proteomics and biomarker discovery. Disease Markers 2002; 18: 99–105
  • Srinivas P. Proteomics for cancer biomarker discovery. Clinical Chemistry 2002; 48: 1160–1169
  • Vainio H. Use of biomarkers in risk assessment. International Journal of Hygiene and Environmental Health 2001; 204: 91–102
  • Wright G. J. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Reviews in Molecular Diagnosis 2002; 2: 549–563

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.